A new drug aimed at helping people with chronic heart failure has been approved for use in the UK.

Ivabradine has been licensed following a study of chronic heart failure patients involving more than 6,000 people. The drug could help improve both symptoms of heart failure and a patient’s quality of life where other drugs have failed.

Maureen Talbot, BHF's Senior Cardiac Nurse, said:
"Knowing doctors have another option to offer those patients whose condition is particularly difficult to treat is really positive news."

Source: The British Heart Foundation